Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

6 Months Ended

Jun. 30, 2021

Balance Sheet Related Disclosures [Abstract]

SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

NOTE 4 — SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

Inventories consisted of the following (in thousands):

	June 30, 2021			December 31, 2020
Raw materials and components	$	1,439		$	1,486
Work-in-process		315			721
Finished goods		6,276			6,064
Inventory reserve		(1,487	)		(1,184	)
Total	$	6,543		$	7,087

Prepaid expenses and other current assets consisted of the following (in thousands):

	June 30, 2021		December 31, 2020
Prepaid insurance	$	355	$	388
Prepaid expenses		332		454
Due from EJ Holdings		509		376
Other current assets		271		267
Total	$	1,467	$	1,485

Property and equipment consisted of the following (in thousands):

	June 30, 2021			December 31, 2020
Equipment	$	332		$	347
Leasehold improvements		39			39
Furniture and fixtures		99			99
Total property and equipment		470			485
Less: accumulated depreciation		(371	)		(365	)
Property and Equipment, net	$	99		$	120

During the three months ended June 30, 2021 and 2020, depreciation expense was approximately $12,000 and $11,000 respectively. During the six months ended June 30, 2021 and 2020, depreciation expense were approximately $23,000 for both period.